Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1546422

This article is part of the Research Topic Lymphocytes and Autoimmune Disease: from molecular mechanism to clinical implications View all 6 articles

The nature of the post-translational modifications of the autoantigen LL37 influences the autoreactive T-helper cell phenotype in psoriasis

Provisionally accepted
  • 1 National Institute of Health (ISS), Rome, Lazio, Italy
  • 2 Centro di Ricerca Humanitas, Skin Pathology Lab, Rozzano, Milan, Italy,, Rozzano, Milan, Italy
  • 3 Humanitas University, Rozzano, Italy
  • 4 Policlinico Tor Vergata, Rome, Lazio, Italy
  • 5 Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Vaud, Switzerland
  • 6 University of Rome Tor Vergata, Roma, Lazio, Italy

The final, formatted version of the article will be published soon.

    Psoriasis is a chronic skin disease evolving to psoriatic arthritis (PsA) in 30% of cases.LL37 is a psoriasis T-cell autoantigen and, in complex with self-DNA/RNA, a trigger of type I interferon (IFN-I) and pro-inflammatory factors in dendritic cells. LL37 can undergo irreversible post-translational modifications (PTMs), namely citrullination and carbamylation, which are linked to a neutrophil-dominated inflammation. Notably, in PsA, carbamylated and citrullinated LL37 (carb-LL37 and cit-LL37) become antibody targets.Here, we analyze the presence of, and the T-cell and antibody reactivity to, cit-LL37 and carb-LL37, to address occurrence and significance of these PTMs in psoriasis. The presence of modified LL37 in skin biopsies was assessed by laser scanner confocal microscopy (LSCM); T-cell responses to modified LL37 was assessed by Ki67 assay and intracellular cytokines staining using flow-cytometry; serum autoantibodies to the same antigens were tested by ELISA. The results show that: native and modified LL37 (both carb-LL37 and cit-LL37) are detectable in psoriatic skin, but not in healthy donors (HD) skin, where they colocalize with neutrophil infiltrates and neutrophil extracellular trap formation (NETosis).Psoriatic T-cells and antibodies recognize native LL37, cit-LL37 and carb-LL37, but only CD4-T-cell responses to native LL37 and carb-LL37 correlate with psoriasis area severity 2 index (PASI), whereas CD8-T-cell responses to the same peptides correlate with PASI in the HLA-Cw6*02-positive subgroup. CD4-T-cells specific for modified LL37 express heterogeneous T-helper (Th) phenotypes: native/carb-LL37-specific T-cells mainly manifest a Th1/Th17-like phenotype, whereas cit-LL37-specific T-cells resemble Thfollicular (Thf)-like cells. In vitro T-cell polarization experiments suggest that distinct proinflammatory effects of LL37 and modified LL37, in complex with self-nucleic acids, may concur to these phenomena. This is the first evidence in psoriasis that PTMs of an autoantigen with innate immune cell stimulatory ability dictates autoreactive Th-cellpolarization. This data, obtained using LL37 as a model autoantigen, indicate that citrullination and carbamylation pathways may play a role in the psoriasis course generating epitopes to which immunological tolerance does not exist, and potentially concur to PsA development.

    Keywords: psoriasis1, autoreactive responses2, carbamylation3, Citrullination4, autoantigens5, LL376, Thelper cell polarization8

    Received: 16 Dec 2024; Accepted: 18 Mar 2025.

    Copyright: © 2025 Lande, Mennella, Palazzo, Favaro, Facheris, Mancini, Ocone, Botti, Falchi, Pietraforte, Conrad, Bianchi, Costanzo and Frasca. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Loredana Frasca, National Institute of Health (ISS), Rome, 00161, Lazio, Italy

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more